Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2026)

Revolution Medicines' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 67.17% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 45.74% decrease from a year earlier, with the FY2025 full-year figure at $27.8 million, down 37.55% from the prior year.
• Amortizatization of Intangibles declined to $3.2 million in Q1 2026 per RVMD's latest filing, from $4.6 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $15.2 million in Q1 2024 and bottomed at -$648000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $5.1 million (2023), against an average of $5.9 million.
• Across the five-year window, Amortizatization of Intangibles jumped 18066.67% in 2023 and sank 67.17% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $2.6 million in 2022, then soared by 233.06% to $8.6 million in 2023, then climbed by 2.24% to $8.8 million in 2024, then tumbled by 48.4% to $4.6 million in 2025, then slipped by 29.23% to $3.2 million in 2026.
• Per Business Quant, the three latest RVMD Amortizatization of Intangibles figures stand at $3.2 million (Q1 2026), $4.6 million (Q4 2025), and $5.7 million (Q3 2025).